Sign up to save your podcasts
Or
Share Evolving Care in Duchenne Muscular Dystrophy (DMD)
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Evolving Care in Duchenne Muscular Dystrophy (DMD)
In this episode, our guest speaker Dr. Diana Castro, Associate Professor of Pediatrics, Neurology and Neurotherapeutics at the University of Texas Southwestern shares her extensive clinical knowledge and discusses the clinical, diagnostic and medical landscape in DMD, as well as management approaches in the care of DMD.
Diana Castro, M.D., is a neurologist at Children’s Health℠ who specializes in pediatric neurology and neuromuscular medicine. She is also an assistant professor of pediatrics and neurology and neurotherapeutics at UT Southwestern Medical Center. She is the co-director of the Muscular Dystrophy Association Clinic in Dallas and is involved in multiple research protocols for spinal muscular atrophy (SMA) and Duchenne muscular dystrophy in the pediatric population.
PTC Therapeutics has provided financial compensation to Dr Castro for the time to conduct this interview.
US-DMD-0252 I 09/28/21
Trademarks, registered or otherwise, are the property of their respective owner(s).
© 2021 PTC Therapeutics, Inc. All Rights Reserved.
Hosted on Acast. See acast.com/privacy for more information.
View all episodes
By PTC Therapeutics
4.8
66 ratings
In this episode, our guest speaker Dr. Diana Castro, Associate Professor of Pediatrics, Neurology and Neurotherapeutics at the University of Texas Southwestern shares her extensive clinical knowledge and discusses the clinical, diagnostic and medical landscape in DMD, as well as management approaches in the care of DMD.
Diana Castro, M.D., is a neurologist at Children’s Health℠ who specializes in pediatric neurology and neuromuscular medicine. She is also an assistant professor of pediatrics and neurology and neurotherapeutics at UT Southwestern Medical Center. She is the co-director of the Muscular Dystrophy Association Clinic in Dallas and is involved in multiple research protocols for spinal muscular atrophy (SMA) and Duchenne muscular dystrophy in the pediatric population.
PTC Therapeutics has provided financial compensation to Dr Castro for the time to conduct this interview.
US-DMD-0252 I 09/28/21
Trademarks, registered or otherwise, are the property of their respective owner(s).
© 2021 PTC Therapeutics, Inc. All Rights Reserved.
Hosted on Acast. See acast.com/privacy for more information.